The issue of physician assisted suicide can cause people to fervently pick one side or another. For some, their belief is so strong that they are moved to do things they may not have done in their career beforehand.
For many psychiatrists one of their biggest challenges in their daily practice is working to show patients that suicide is not the solution to their problems. Changes in the criteria for physician assisted suicide in Europe which include allowing mental illness as a criteria can fly in the face of that mission.
The issue of physician assisted suicide is one that has been debated both in the medical community and in the general population. Recent law changes by some European countries have brought the issue to the forefront perhaps more than ever before.
A new model that combines real-world prices with outcome data from both controlled trials and clinical practice indicates that the immediate use of tumor necrosis factor inhibitors (anti-TNFs) is a cost-effective way to achieve good first-year outcomes in patients newly diagnosed with both plaque psoriasis and psoriatic arthritis.